课题基金 / 基金详情

I-Corps: A home-based kit for monitoring melatonin profile in insomnia patients

I-Corps: A home-based kit for monitoring melatonin profile in insomnia patients
I-Corps:用于监测失眠患者褪黑激素水平的家用套件
批准号:
2131820
负责人:
Katsuo Kurabayashi
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-05-15 至 2021-10-31

项目摘要

项目成果

Katsuo Kurabayashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The broader impact/commercial potential of this I-Corps project is the development of a device to test individuals with circadian rhythm sleep disorders at home. Conventional testing, called Dim Light Melatonin Onset (DLMO) testing, is typically conducted in a laboratory by trained staff. The proposed in-home DLMO device may enable biomedical researchers to understand the circadian rhythms and related health impacts of patients otherwise unable to participate in studies. In addition, the technology may allow for medical diagnosis of sleep disorders at high certainty, which may help the ~20% of sleep insomnia patients with circadian rhythm disorders to receive the proper treatment while eliminating months of trial-and-error sleep treatments. The project will target melatonin circadian rhythm researchers and individuals homebound due to other illness or senior patients as potential customers. This I-Corps project is based on the development of a device for home-based Dim Light Melatonin Onset (DLMO) testing that does not require the use of trained staff. Dim Light Melatonin Onset (DLMO) is a key parameter for the diagnosis of circadian rhythm sleep disorders. Currently, the only way to accurately measure a person’s DLMO is in a sleep facility with trained staff collecting saliva samples from a patient for 6 hours before bedtime. This is an expensive procedure and makes it impossible for individuals that cannot be in a lab for an entire evening to have their DLMO measured. The proposed device is an intelligent machine that performs the tasks of a lab technician. It allows the user to perform the saliva sample collection at home, while monitoring whether the user successfully follows the protocol. In addition, the proposed device uses the best performing melatonin radioimmunoassay (RIA), validated via independent research studies, and the device reports the sample collection times, sample temperatures from the moment collected until returned to the researcher, and whether the participant wore blue blocking glasses as required.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
I-Corps: A diagnostic platform for the analysis of biomarkers in multiplexed immunoassays
RAPID: Plasmonic Optoelectronic Immunosensing for Point-Of-Care Virus Infection Screening
A Nanotechnology-Based Wearable Biological Sensor for Continuous Monitoring of Inflammatory Immune Diseases
Localized Surface Plasmon Resonance (LSPR) Biosensing Microarray for Multiplex, Real-time Single-Cell Immunophenotyping
国内基金
海外基金
基于AI-Home模式的脑肿瘤术后患者康复体系构建及实证研究
  • 批准号:
    2026JJ82675
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    王睿
  • 依托单位: